Trials / Completed
CompletedNCT04682184
A Study of Continuous Heart Rate Monitoring in Healthy Participants
A Study to Investigate Continuous Heart Rate Monitoring Using a Chest-worn Biosensor on the Background of Drug-induced Positive and Negative Heart Rate Changes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study in healthy participants is to find out whether a heart rate monitor will accurately pick up changes in heart rate caused by 2 different medications (pseudoephedrine and metoprolol), on the background of daily activities. Participants will wear a patch heart rate and activity monitor on the chest for the entire study. The study will last about 36 days and may include up to seven visits to the study center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propranolol | Administered orally. |
| DRUG | Pseudoephedrine | Administered orally. |
| DEVICE | Wearable Biosensor Patch Device | Biosensor patch device attached to the chest and worn throughout the trial with replacement of biosensor every 7 days. |
Timeline
- Start date
- 2021-01-27
- Primary completion
- 2021-03-25
- Completion
- 2021-03-25
- First posted
- 2020-12-23
- Last updated
- 2021-04-19
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT04682184. Inclusion in this directory is not an endorsement.